Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Palisade Bio (PALI)
NASDAQ:PALI
Holding PALI?
Track your performance easily
PALI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.33 - $22.35
Previous CloseN/A
Volume307.14K
Average Volume (3M)3.06M
Market Cap
$4.20M
Enterprise Value-$2.35M
Total Cash (Recent Filing)$713.00K
Total Debt (Recent Filing)$1.25M
Price to Earnings (P/E)―
Beta2.12
Next Earnings
Mar 14, 2025EPS Estimate
-2.58Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-15.04
Shares Outstanding2,765,980
10 Day Avg. Volume1,485,197
30 Day Avg. Volume3,064,604
Standard Deviation0.27
R-Squared0.08
Alpha-0.10
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)8.08
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.56
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-9.42
Enterprise Value/Ebitda0.17
Forecast
1Y Price Target
$23.00Price Target Upside1508.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Palisade Bio News
Ownership Overview
2.51% Insiders
0.54% Mutual Funds
1.88% Other Institutional Investors
94.91% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
PALI FAQ
What was Palisade Bio’s price range in the past 12 months?
Palisade Bio lowest stock price was $1.33 and its highest was $22.35 in the past 12 months.
What is Palisade Bio’s market cap?
Palisade Bio’s market cap is $4.20M.
When is Palisade Bio’s upcoming earnings report date?
Palisade Bio’s upcoming earnings report date is Mar 14, 2025 which is in 42 days.
How were Palisade Bio’s earnings last quarter?
Palisade Bio released its earnings results on Nov 12, 2024. The company reported -$2.32 earnings per share for the quarter, beating the consensus estimate of -$3.353 by $1.033.
Is Palisade Bio overvalued?
According to Wall Street analysts Palisade Bio’s price is currently Undervalued.
Does Palisade Bio pay dividends?
Palisade Bio does not currently pay dividends.
What is Palisade Bio’s EPS estimate?
Palisade Bio’s EPS estimate is -2.58.
How many shares outstanding does Palisade Bio have?
Palisade Bio has 2,765,980 shares outstanding.
What happened to Palisade Bio’s price movement after its last earnings report?
Palisade Bio reported an EPS of -$2.32 in its last earnings report, beating expectations of -$3.353. Following the earnings report the stock price went down -4.418%.
Which hedge fund is a major shareholder of Palisade Bio?
Currently, no hedge funds are holding shares in PALI
---
Company Description
Palisade Bio
Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.
---
PALI Stock 12 Month Forecast
Average Price Target
$23.00
▲(1508.39% Upside)
Technical Analysis
Ardelyx
―
Ascendis Pharma
―
Voyager Therapeutics
―
Bioxcel Therapeutics
―
Mirum Pharmaceuticals
―
Best Analysts Covering PALI
1 Year
1 Year Success Rate
0/15 ratings generated profit
1 Year Average Return
-69.45%
reiterated a buy rating 2 months ago
Copying Naz Rahman's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -69.45% per trade.
---